People: argenx SE (ARGX.OQ)
2 Jul 2020
Dr. Werner Lanthaler Ph.D. serves as Non-Executive Independent Vice Chairman of the Board of the Company. Dr. Werner Lanthaler has served as a member of the Company's board of directors since July 2014. Dr. Lanthaler is the chief executive officer of Evotec AG, a global drug discovery research organization, a position he has held since March 2009. Dr. Lanthaler previously served on the supervisory boards of Bioxell SpA and Pantec Biosolutions AG. Dr. Lanthaler holds a degree in psychology from Universitaet Wien, a Ph. D. in business administration from Universitaet Wien of Economics and Business, and a Master’s degree in public administration from Harvard University. He is Chairman of the Audit Committee, and Member of the Remuneration and Nomination Committee of the Company.
|Total Annual Compensation, EUR||712,170|
|Restricted Stock Award, EUR||--|
|Long-Term Incentive Plans, EUR||--|
|All Other, EUR||--|
|Fiscal Year Total, EUR||712,170|